Teewinot Life Sciences Corporation's Subsidiary, Teewinot Technologies, Ltd. Announced Today: Grant of a New Patent with Broad Claims to Biosynthetic Production of Cannabinoid Pharmaceuticals

Furthers Mission to Address Unmet Medical Needs Across the Globe TAMPA, Florida, Jan. 22, 2018 /PRNewswire/ -- Teewinot Life Sciences Corporation, a global leader in the production and clinical development of cannabinoid-based pharmaceuticals, and its wholly owned Irish...

from PR Newswire: //http://ift.tt/2E0z112